The GPR37 is integral to the pathological processes underlying various brain disorders, with its deletion shown to impair oligodendrocyte function and elevate susceptibility to demyelinating diseases, notably MS (Smith et al., 2017). This evidence concerns the gene GPR37 and myeloid sarcoma.